Australia markets closed

Armata Pharmaceuticals, Inc. (TG1N.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.3800+0.0200 (+0.85%)
As of 08:34AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
30,262
33,770
35,017
20,015
14,444
-
Selling general and administrative
7,850
11,649
7,437
8,281
7,966
-
Total operating expenses
32,666
40,890
36,946
23,822
21,587
-
Operating income or loss
-32,666
-40,890
-36,946
-23,822
-21,587
-
Interest expense
0
2,626
0
64
628
-
Total other income/expenses net
-35,571
-25,708
-
726
6
445
Income before tax
-32,650
-69,045
-36,917
-23,155
-22,181
-
Income from continuing operations
-32,650
-69,045
-36,917
-23,155
-22,181
-
Net income
-32,650
-69,045
-36,917
-23,155
-22,181
-
Net income available to common shareholders
-32,650
-69,045
-36,917
-23,155
-22,181
-
Basic EPS
-1.65
-1.91
-1.08
-0.96
-1.35
-
Diluted EPS
-1.65
-1.91
-1.08
-0.96
-1.35
-
Basic average shares
36,066
36,076
34,294
24,104
16,415
-
Diluted average shares
36,066
36,076
34,294
24,104
16,415
-